These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 8212845)

  • 1. Long-term antibody responses in mice following subcutaneous immunization with ovalbumin entrapped in biodegradable microparticles.
    O'Hagan DT; Jeffery H; Davis SS
    Vaccine; 1993; 11(9):965-9. PubMed ID: 8212845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled release microparticles for vaccine development.
    O'Hagan DT; Jeffery H; Roberts MJ; McGee JP; Davis SS
    Vaccine; 1991 Oct; 9(10):768-71. PubMed ID: 1759495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of mucosal and systemic immune responses by immunization with ovalbumin entrapped in poly(lactide-co-glycolide) microparticles.
    Maloy KJ; Donachie AM; O'Hagan DT; Mowat AM
    Immunology; 1994 Apr; 81(4):661-7. PubMed ID: 7518802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biodegradable microparticles for oral immunization.
    O'Hagan DT; McGee JP; Holmgren J; Mowat AM; Donachie AM; Mills KH; Gaisford W; Rahman D; Challacombe SJ
    Vaccine; 1993; 11(2):149-54. PubMed ID: 8438613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The stability and immunogenicity of a protein antigen encapsulated in biodegradable microparticles based on blends of lactide polymers and polyethylene glycol.
    Lavelle EC; Yeh MK; Coombes AG; Davis SS
    Vaccine; 1999 Feb; 17(6):512-29. PubMed ID: 10075157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced secretory IgA and systemic IgG antibody responses after oral immunization with biodegradable microparticles containing antigen.
    Challacombe SJ; Rahman D; Jeffery H; Davis SS; O'Hagan DT
    Immunology; 1992 May; 76(1):164-8. PubMed ID: 1628895
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation: particle size study.
    Uchida T; Goto S
    Biol Pharm Bull; 1994 Sep; 17(9):1272-6. PubMed ID: 7841952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen.
    Coombes AG; Lavelle EC; Jenkins PG; Davis SS
    Vaccine; 1996 Oct; 14(15):1429-38. PubMed ID: 8994318
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immune response to a model antigen associated with PLG microparticles prepared using different surfactants.
    Rafati H; Lavelle EC; Coombes AG; Stolnik S; Holland J; Davis SS
    Vaccine; 1997 Dec; 15(17-18):1888-97. PubMed ID: 9413098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biodegradable microparticles as controlled release antigen delivery systems.
    O'Hagan DT; Rahman D; McGee JP; Jeffery H; Davies MC; Williams P; Davis SS; Challacombe SJ
    Immunology; 1991 Jun; 73(2):239-42. PubMed ID: 2071168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems.
    Delgado A; Lavelle EC; Hartshorne M; Davis SS
    Vaccine; 1999 Jul; 17(22):2927-38. PubMed ID: 10438065
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigen-specific IgA and IgG responses in calves inoculated intranasally with ovalbumin encapsulated in poly(DL-lactide-co-glycolide) microspheres.
    Kavanagh OV; Earley B; Murray M; Foster CJ; Adair BM
    Vaccine; 2003 Oct; 21(27-30):4472-80. PubMed ID: 14505930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biodegradable microparticles of influenza viral vaccine: comparison of the effects of routes of administration on the in vivo immune response in mice.
    Chattaraj SC; Rathinavelu A; Das SK
    J Control Release; 1999 Mar; 58(2):223-32. PubMed ID: 10053195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Size effect on systemic and mucosal immune responses induced by oral administration of biodegradable microspheres.
    Tabata Y; Inoue Y; Ikada Y
    Vaccine; 1996 Dec; 14(17-18):1677-85. PubMed ID: 9032899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with a soluble recombinant HIV protein entrapped in biodegradable microparticles induces HIV-specific CD8+ cytotoxic T lymphocytes and CD4+ Th1 cells.
    Moore A; McGuirk P; Adams S; Jones WC; McGee JP; O'Hagan DT; Mills KH
    Vaccine; 1995 Dec; 13(18):1741-9. PubMed ID: 8701587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation.
    Uchida T; Goto S; Foster TP
    J Pharm Pharmacol; 1995 Jul; 47(7):556-60. PubMed ID: 8568620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral immunogenicity of the inactivated Vibrio cholerae whole-cell vaccine encapsulated in biodegradable microparticles.
    Yeh MK; Liu YT; Chen JL; Chiang CH
    J Control Release; 2002 Aug; 82(2-3):237-47. PubMed ID: 12175740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactive Vibrio cholerae whole-cell vaccine-loaded biodegradable microparticles: in vitro release and oral vaccination.
    Yeh M; Chiang C
    J Microencapsul; 2004 Feb; 21(1):91-106. PubMed ID: 14718189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Encapsulation of antigen in poly(D,L-lactide-co-glycolide) microspheres protects from harmful effects of γ-irradiation as assessed in mice.
    Mohanan D; Gander B; Kündig TM; Johansen P
    Eur J Pharm Biopharm; 2012 Feb; 80(2):274-81. PubMed ID: 22024408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids.
    Takahata H; Lavelle EC; Coombes AG; Davis SS
    J Control Release; 1998 Jan; 50(1-3):237-46. PubMed ID: 9685890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.